Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Lisa Levin

Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session


  • NextPlay Technologies, Inc. (NASDAQ:NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
  • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) gained 44.1% to $4.6852. Ascent Solar recently named Jeffrey Max as CEO.
  • American Rebel Holdings, Inc. (NASDAQ:AREB) rose 32.4% to $0.3640 after the company announced it sees $5 million in pro forma Q3 gross revenue.
  • Alfi, Inc. (NASDAQ:ALF) jumped 30.8% to $0.3390.
  • Rubicon Technologies, Inc. (NYSE:RBT) gained 30.3% to $2.5790.
  • NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) rose 26% to $4.65. NGM Biopharmaceuticals Director David Goeddel V bought a total of 130,000 shares at an average price of $3.56.
  • Cabaletta Bio, Inc. (NASDAQ:CABA) jumped 24% to $1.62. Cabaletta Bio President and CEO Steven Nichtberger acquired a total of 8,127 shares at an average price of $1.25.
  • AppTech Payments Corp. (NASDAQ:APCX) rose 23.3% to $0.7459.
  • Skillz Inc. (NYSE:SKLZ) gained 22.6% to $1.08. Skillz is expected to release its Q3 results after the close of the market on Wednesday, November 2, 2022.
  • Inc. (NYSE:POL) rose 21.1% to $0.63.
  • Invivyd, Inc. (NASDAQ:IVVD) jumped 19.9% to $3.91. Invivyd recently appointed Fred Driscoll as interim Chief Financial Officer.
  • MicroCloud Hologram Inc. (NASDAQ:HOLO) gained 19.5% to $2.93.
  • VolitionRx Limited (NASDAQ:VNRX) gained 19.3% to $1.73. Volition signed global supply agreement for Nu.Q Vet Cancer Test.
  • PaxMedica, Inc. (NASDAQ:PXMD) jumped 18.8% to $3.2108.
  • Telos Corporation (NASDAQ:TLS) shares climbed 18.8% to $9.94. Needham maintained Telos with a Buy and raised the price target from $10 to $13.
  • PDS Biotechnology Corporation (NASDAQ:PDSB) surged 18% to $4.77. PDS Biotech recently announced expanded interim data in the Phase 2 clinical trial investigating the PDS0101-based triple combination therapy.
  • NVE Corporation (NASDAQ:NVEC) rose 17.9% to $56.86. NVE posted Q2 EPS of $1.26.
  • COMSovereign Holding Corp. (NASDAQ:COMS) gained 17.9% to $0.1035 after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.
  • Vertiv Holdings Co (NYSE:VRT) surged 15% to $13.11 following a Bloomberg report suggesting Starboard Value took a stake in the company.
  • Monarch Casino & Resort, Inc. (NASDAQ:MCRI) gained 14.5% to $70.50. Stifel upgraded Monarch Casino & Resort from Hold to Buy and raised the price target from $70 to $77.
  • Super Micro Computer, Inc. (NASDAQ:SMCI) shares gained 13.2% to $62.91 after the company raised Q1 net sales guidance and adjusted EPS guidance above estimates.
  • Pineapple Energy Inc. (NASDAQ:PEGY) rose 13% to $4.2946 after dipping over 20% on Wednesday.
  • Mullen Automotive, Inc. (NASDAQ:MULN) rose 12% to $0.3808. Mullen Automotive shares jumped 57% on Wednesday after the company announced US Bankruptcy Court approval of its acquisition of ELMS assets.
  • Bright Health Group, Inc. (NYSE:BHG) climbed 11.4% to $1.07.
  • Kaiser Aluminum Corporation (NASDAQ:KALU) gained 11.2% to $74.47 after the company reported better-than-expected Q3 sales results.
  • Enservco Corporation (NYSE:ENSV) rose 6.1% to $1.4325 after the company swung to a profit in the first quarter.
  • International Business Machines Corporation (NYSE:IBM) shares rose 4.3% to $127.82 after the company reported better-than-expected Q3 EPS and sales results.


  • Talaris Therapeutics, Inc. (NASDAQ:TALS) shares dipped 41.9% to $1.4050 after the company announced it received a report of a patient death, which triggered a pre-specified, temporary stopping requirement and review by the FREEDOM-1 Data Monitoring Committee.
  • LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) fell 24.6% to $7.85. LMF Acquisition Opportunities recently announced stockholders approved the previously-announced business combination with SeaStar Medical.
  • PARTS iD, Inc. (NYSE:ID) dropped 20.8% to $1.3699.
  • SenesTech, Inc. (NASDAQ:SNES) declined 20.6% to $0.2701.
  • Scopus BioPharma Inc. (NASDAQ:SCPS) dipped 19.9% to $0.2979. Scopus BioPharma on Tuesday announced the completion of its recapitalization.
  • Stabilis Solutions, Inc. (NASDAQ:SLNG) dropped 19% to $8.17.
  • Helbiz, Inc. (NASDAQ:HLBZ) dropped 18.6% to $0.2767.
  • Rumble Inc. (NASDAQ:RUM) fell 18.3% to $6.66 after The Bear Cave issued a cautious report on the stock.
  • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) dropped 18% to $0.1927. Kala Pharmaceuticals announced a 1-for-50 reverse stock split, effective 4:05 p.m. Oct. 20.
  • Zovio Inc (NASDAQ:ZVO) shares fell 16% to $0.1764 after gaining 5% on Wednesday.
  • Mana Capital Acquisition Corp. (NASDAQ:MAAQ) declined 15.8% to $8.50.
  • Fulcrum Therapeutics, Inc. (NASDAQ:FULC) dropped 15.5% to $5.51.
  • First Internet Bancorp (NASDAQ:INBK) fell 15.4% to $26.06 following downbeat quarterly earnings.
  • Concord Medical Services Holdings Limited (NYSE:CCM) dipped 14.6% to $1.35.
  • Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) fell 14.4% to $5.49 after the company reported mixed Q3 earnings results.
  • Calliditas Therapeutics AB (NASDAQ:CALT) dropped 11.7% to $12.00.
  • Heritage-Crystal Clean, Inc (NASDAQ:HCCI) fell 11.7% to $28.53. Heritage-Crystal Clean posted Q3 EPS of $1.01.
  • The Allstate Corporation (NYSE:ALL) dropped 11.5% to $119.57 after the company announced estimated results for Q3'22 of a net loss between $675 million and $725 million.
  • Amprius Technologies, Inc. (NASDAQ:AMPX) fell 11.1% to $9.78. Amprius Technologies shares jumped 77% on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
  • RedHill Biopharma Ltd. (NASDAQ:RDHL) shares fell 10.4% to $0.6090. RedHill Biopharma shares jumped around 47% on Wednesday after the company announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
  • WD-40 Company (NASDAQ:WDFC) dropped 9.8% to $154.01 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued FY23 EPS guidance below analyst estimates.
  • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares fell 9.5% to $0.1091 after gaining over 20% on Wednesday. The company announced it paused its REM-001 program to conserve funds to support its VAL-083 international registrational study.
  • Triumph Bancorp, Inc. (NASDAQ:TBK) fell 8.7% to $49.72 after the company reported worse-than-expected Q3 EPS and sales results.
  • Trupanion, Inc. (NASDAQ:TRUP) dropped 8.3% to $48.05.
  • Synovus Financial Corp. (NYSE:SNV) fell 7.8% to $38.08 following Q3 results.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 7.5% to $0.5377 after dipping 20% on Wednesday. Acorda Therapeutics recently announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
  • The Western Union Company (NYSE:WU) dropped 6.8% to $13.27. The company said it sees FY22 adjusted EPS of $1.75-$1.85.
  • Nokia Oyj (NYSE:NOK) shares fell 6.3% to $4.2750 after reporting Q3 earnings.
  • Tesla, Inc. (NASDAQ:TSLA) fell 4.8% to $211.44. Tesla reported better-than-expected earnings for its third quarter, while sales missed estimates. The company also reported a year over year decrease in Q3 total deliveries.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.